期刊文献+

解毒活血法对UUO大鼠MCP-1的影响 被引量:3

Effects of Jiedu Huoxue Therapy on the MCP-1 in Rats with Unilateral Ureteral Obstruction
下载PDF
导出
摘要 目的采用单侧输尿管梗阻的方法建立肾小管间质纤维化模型,通过观察解毒活血法对大鼠肾组织单核细胞趋化蛋白-1(monocyte chemoattractant protein-1,MCP-1)的影响,探讨其对UUO大鼠的保护作用及可能机制。方法 SD大鼠随机分为假手术组,模型组,缬沙坦组,解毒活血低剂量组,解毒活血高剂量组,每组10只。除假手术组,其余各组大鼠结扎左侧输尿管复制UUO模型。所有大鼠灌胃给药,缬沙坦组给予26 mg/(kg.d);解毒活血低剂量组予解毒活血中药12 g生药/(kg.d);解毒活血高剂量组予24 g生药/(kg.d),假手术组和模型组予等容量生理盐水,共14天。左肾组织行HE、Masson染色,观察病理形态学改变,免疫组化检测肾组织中MCP-1的蛋白表达。结果模型组大鼠MCP-1呈强阳性表达,各治疗组表达较模型组明显减弱。结论解毒活血方药可降低肾组织中MCP-1的高表达,通过抑制炎症反应来减缓肾小管间质纤维化的进程。 Objective Animal model with TIF made by unilateral ureteral obstruction(UUO),the study is to observe the effects of Jiedu Huoxue therapy on the expression of monocyte chemoattractant protein-1(MCP-1) in UUO rats,and to explore the protective effect and possible mechanism of Jiedu Huoxue therapy in UUO rats.Methods Fifty Sprague-Dawley rats were randomized equally into 5 groups:Control group,UUO group,Valsartan group,low-dose of Jiedu Huoxue decoction group and high-dose of Jiedu Huoxue decoction group.Except the Control group,rats in other four groups were made into UUO model by ligaturing the left ureter.All rats were treated with drugs by oral infusion once a day.Rats in Valsartan group,Jiedu Huoxue decoction low-dose group and high-dose group were treated respectively with Valsartan 26mg/kg·d,Jiedu Huoxue decoction 12g/kg·d and 24g/kg·d for fourteen days.The protein expressions of MCP-1 in rats' kidney were detected by immunohistochemical.Results The expression of MCP-1 were increased significantly in the model group.After treatment,the expression of MCP-1 were significantly down-regulated in the treatment groups.Conclusion Jiedu Huoxue decoction is able to reduce the high expressions of MCP-1,and to retard the progress of renal tubular interstitial fibrosis by inhibiting inflammatory reaction.
出处 《时珍国医国药》 CAS CSCD 北大核心 2013年第3期623-624,共2页 Lishizhen Medicine and Materia Medica Research
基金 河北省科技支撑计划项目(No.10276105-D) 河北省中医药管理局科研计划项目(No.2010005)
关键词 肾小管间质纤维化 单侧输尿管梗阻 解毒活血法 单核细胞趋化蛋白-1 Renal tubular interstitial fibrosis Unilateral ureteral obstruction Jiedu Huoxue therapy Monocyte chemoattractant protein-1
  • 相关文献

参考文献7

  • 1Norman UT, Fine LG. Progressive renal disease: fibroblasts,extracellular matrix and integrins [ J ]. Exp Nephrol, 1999,7 ( 2 ) : 167.
  • 2Elmer F ,F[oege J. Novel insight into renal fibrosis[ J]. Curr Opin Neph- rol Hypertens ,2003,12 (3) :227.
  • 3Nath KA. Tubulointe,:titial changes as a major determinant in the pro- gression of renal damage [ J ]. Am J Kidney Dis, 1992,20 (1) :1.
  • 4欧阳春,宁建平,周巧玲.单侧输尿管梗阻大鼠肾小管间质MCP-1的表达及其意义[J].中南大学学报(医学版),2004,29(5):558-561. 被引量:13
  • 5Chatziantoniou C, Dussaule JC. ls kidney injury a reversible process? [J]. Curr Opin INephrol Hypertens,2008,17( 1 ) :76.
  • 6Eitner F, Floege J. Novel insights into renal fibrosis [ J ]. Curt Opin Nephrol Hypertens,2003,12(3 ) :227.
  • 7Eddy A. Role of cellular infiltrates in response to proteinuria[ J]. Am J Kidney Dis,2001,37(2) :25.

二级参考文献10

  • 1[1]Becker GJ, Hewitson TD. The role of tubulointerstitial injury in chronic renal failure[J]. Curr Opin Nephrol Hypertens,2000,9(2):133-138.
  • 2[2]Eddy A. Role of cellular infiltrates in response to proteinuria[J]. Am J Kidney Dis,2001, 37( Suppl 2):S25-S29.
  • 3[3]Luster AD. Chemokines--chemotactic cytokines that mediate inflammation[J]. N Engl J Med,1998 ,338(7):436-445.
  • 4[4]Lange-Sperandio B, Cachat F, Thornhill BA, et al. Selectins mediate macrophage infiltration in obstructive nephropathy in newborn mice[J]. Kidney Int,2002,61(2):516-524.
  • 5[5]Strutz F, Muller GA. Interstitial pathomechanisms underlying progressive tubulointerstitial damage[J]. Kidney Blood Press Res,1999,22(1-2):71-80.
  • 6[6]Kipari T, Hughes J. Macrophage-mediated renal cell death[J]. Kidney Int,2002,61(2):760-761.
  • 7[7]Wada T, Furuichi K, Sakai N, et al. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy[J]. Kidney Int,2000,58(4):1492-1499.
  • 8[8]Panzer U, Thaiss F, Zahner G,et al. Monocyte chemoattractant protein-1 and osteopontin differentially regulate monocytes recruitment in experimental glomerulonephritis[J]. Kidney Int, 2001,59(5):1762-1769.
  • 9[9]Banba N, Nakamura T, Matsumura M, et al. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy[J]. Kidney Int,2000,58(2):684-690.
  • 10[10]Viedt C, Dechend R, Fei J,et al. MCP-1 induces inflammatory activation of human tubular epithelial cells: involvement of the transcription factors, nuclear factor- B and activating protein-1[J]. J Am Soc Nephrol,2002,13(6):1534-1547.

共引文献12

同被引文献75

  • 1万毅刚,孙伟,陈晓艳,杨海明,葛明,戴玮,清水不二雄.雷公藤多苷对抗Thy1.1抗体肾炎肾小球内炎症细胞浸润的抑制作用[J].中国中药杂志,2009,34(1):72-77. 被引量:16
  • 2吴涛,高蕾,李学刚,黄芳芳,宋燕,关广聚.虫草菌丝对慢性肾功能衰竭大鼠微炎症反应的影响[J].中国药理学与毒理学杂志,2010,24(4):274-279. 被引量:5
  • 3张辉,杨爱成,李忠琳.肾康注射液对肾功能中度异常的糖尿病肾病患者炎性因子的影响[J].湖北医药学院学报,2013,32(4):295-298. 被引量:5
  • 4曹雪涛.医学免疫学[M].第6版.北京:人民卫生出版社,2013:49-55.
  • 5Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey [J]. Lancet, 2012, 379(9818): 815-822.
  • 6Filiopoulos V, Vlassopoulos D. Inflammatory syndrome in chronic kidney disease: pathogenesis and influence on outcomes [J]. Inf Allergy Drug Targets, 2009, 8(5): 369-382.
  • 7Ahad A, Ganai A A, Mujeeb M, et al. Ellagic acid, an NF-tB inhibitor, ameliorates renal function in experimental diabetic nephropathy [J]. Chem Biol Interact, 2014, 219: 64-75.
  • 8Taslipinar A, Yaman H, Yilmaz M I, et al. The relationship between inflammation endothelial dysfunction and proteinuria in patients with diabetic nephropathy [J]. Scand J Clin Lab lnvest, 2011, 71(7): 606-612.
  • 9Impellizzeri D, Esposito E, Attley J, et al. Targeting inflammation: new therapeutic approaches in chronic kidney disease (CKD) [J]. Pharmacol Res, 2014, 81: 91-102.
  • 10Navarro-Gonzilez J F, Mora-Fernfindez C, Muros de Fuentes M, et al. Inflammatory molecules and pathwaysin the pathogenesis of diabetic nephropathy [J]. Nat Rev Nephrol, 2011, 7(6): 327-340.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部